MedPath

ALCON RESEARCH

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular Hypertension

Phase 2
Completed
Conditions
Open-Angle Glaucoma
Ocular Hypertension
First Posted Date
2006-09-07
Last Posted Date
2008-04-22
Lead Sponsor
Alcon Research
Target Recruit Count
120
Registration Number
NCT00372931
Locations
🇺🇸

San Antonio Site, San Antonio, Texas, United States

A Bioequivalence Study of Tobradex AF

First Posted Date
2006-08-15
Last Posted Date
2012-03-05
Lead Sponsor
Alcon Research
Target Recruit Count
995
Registration Number
NCT00362895
Locations
🇺🇸

Contact Alcon for Trial Location(s), Fort Worth, Texas, United States

A Phase II Study of Anecortave Acetate for the Treatment of Exudative Age-Related Macular Degeneration

Phase 2
Completed
Conditions
AMD
Interventions
First Posted Date
2006-07-04
Last Posted Date
2012-03-06
Lead Sponsor
Alcon Research
Target Recruit Count
128
Registration Number
NCT00346957

Safety/Efficacy of Systane Free vs Refresh Liquigel

Not Applicable
Completed
Conditions
Dry Eye
Interventions
Other: Systane Free Lubricant Eye Drops
Other: Refresh Liquigel Lubricant Eye Drops
First Posted Date
2006-07-04
Last Posted Date
2012-03-05
Lead Sponsor
Alcon Research
Target Recruit Count
100
Registration Number
NCT00348517

Product Preference With Systane Compared to Artificial Tears on Frequency of Drop Use

Not Applicable
Completed
Conditions
Dry Eye
First Posted Date
2006-07-04
Last Posted Date
2012-04-10
Lead Sponsor
Alcon Research
Target Recruit Count
50
Registration Number
NCT00347984
Locations
🇺🇸

Maryland, Andover, Massachusetts, United States

Fluorophotometry Evaluation of Lubricant Eye Drops

Not Applicable
Completed
Conditions
Healthy
Interventions
Other: Refresh Plus Lubricant Eye Drops
Other: Systane Free lubricant eye drops
Other: Visine Tears Lubricant Eye Drops
Other: Refresh Liquigel Lubricant Eye Drops
First Posted Date
2006-07-04
Last Posted Date
2016-11-22
Lead Sponsor
Alcon Research
Target Recruit Count
40
Registration Number
NCT00347854
Locations
🇺🇸

Alcon, Fort Worth, Texas, United States

Safety/Efficacy of Systane Free vs Refresh Tears

Not Applicable
Completed
Conditions
Dry Eye
First Posted Date
2006-07-04
Last Posted Date
2008-09-25
Lead Sponsor
Alcon Research
Target Recruit Count
100
Registration Number
NCT00348322
Locations
🇺🇸

El Paso Facility, El Paso, Texas, United States

Safety of NGOIS Compared to BSS Plus in Pediatric Patients

Phase 3
Completed
Conditions
Cataract
Interventions
Drug: Next Generation Ophthalmic Irrigating Solution (NGOIS)
First Posted Date
2006-06-30
Last Posted Date
2012-03-05
Lead Sponsor
Alcon Research
Target Recruit Count
18
Registration Number
NCT00346528
Locations
🇺🇸

Contact Alcon for Trial Locations, Fort Worth, Texas, United States

Anecortave Acetate Versus Placebo in AMD Patients Following PDT

Phase 2
Completed
Conditions
AMD
First Posted Date
2006-06-30
Last Posted Date
2008-08-05
Lead Sponsor
Alcon Research
Target Recruit Count
136
Registration Number
NCT00346866
Locations
🇺🇸

Facility, Beachwood, Ohio, United States

Compliance With Once Daily Glaucoma Medication

Completed
Conditions
Compliance
Interventions
Behavioral: Intervention
First Posted Date
2006-06-05
Last Posted Date
2016-11-18
Lead Sponsor
Alcon Research
Target Recruit Count
700
Registration Number
NCT00333463
Locations
🇺🇸

Ft. Worth, Ft. Worth, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath